Multiple Sclerosis
Conditions
Interventions
Randomized Blind Clinical Trial Study will be developed with 52 female patients aged between 18 and 59 years old, with a clinical diagnosis of Multiple Sclerosis (MS) who will be randomly distributed
E02.331.800
Sponsors
Universidade Federal de Mato Grosso do Sul
Universidade Federal de Mato Grosso do Sul
Eligibility
Sex/Gender
Female
Age
18 Years to 59 Years
Inclusion criteria
Inclusion criteria: Women; aged 18 to 59 years; with a clinical diagnosis of multiple sclerosis according to the Macnonald classification, of the relapsing type; who have symptoms of urinary disorders for at least six months; diagnosed with detrusor overactivity in the urodynamic test; if you cannot get a urodynamic test, the criterion will be at least three of the following symptoms: urgency, urge urinary incontinence, increased urinary frequency, nocturia and nocturnal enuresis
Exclusion criteria
Exclusion criteria: Skin lesions in the area to be treated; cervical, rectal, or genitourinary cancer; if they are pregnant; cardiac pacemaker carriers; presence of urinary tract infection; cognitive decline or illiteracy; presence of genital prolapses; performing abdominal surgeries less than 6 months ago; who already has some history of previous treatment with pelvic floor exercises; who makes previous use of antimuscarinics or other specific medication to control overactive bladder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effects of transcutaneous tibial electrical stimulation on urinary symptoms and quality of life in women with Multiple Sclerosis. The Qualiveen - Short Form (Q-FS) and Overactivebladder (OAB-V8) questionnaires will be used as an evaluation method | — |
Secondary
| Measure | Time frame |
|---|---|
| The experimental group is expected to have a greater impact on improving symptoms compared to the control group | — |
Countries
Brazil
Contacts
Public ContactFabio Saiki
Universidade Federal de Mato Grosso do Sul
Outcome results
None listed